Clearance of dying cells and autoimmunity

Autoimmunity

Volumn 40, Issue 4, 2007, Pages 267-273

  Michlewska, Sylwia ^a   McColl, Aisleen ^a   Rossi, Adriano ^a   Megson, Ian ^b   Dransfield, Ian ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF THE HIGHLANDS AND ISLANDS   (United Kingdom)

Author keywords

Apoptosis; Autoimmunity; Inflammation; Macrophage; Phagocytosis

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTOANTIBODY; AUTOANTIGEN; CYTOKINE; GLUCOCORTICOID; LIPOXIN A; LIPOXIN DERIVATIVE; MEVINOLIN; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL FUNCTION; CELLULAR IMMUNITY; CLEARANCE; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG MECHANISM; ENZYME ACTIVITY; HOMEOSTASIS; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATORY DISEASE; MACROPHAGE FUNCTION; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; INFLAMMATION; PHAGOCYTES; PHAGOCYTOSIS;

EID: 34249809429     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930701357208     Document Type: Review

References (108)

1. Haslett, C. (1999) Am J Respir Crit Care Med, 160, p. S5.
2. Wyllie, AH, Kerr, JF and Currie, AR (1980) Int Rev Cytol, 68, p. 251.
3. Savill, JS (1989) J Clin Invest, 83, p. 865.
4. Albert, ML (1998) J Exp Med, 188, p. 1359.
5. Dini, L., Rossi, L., Lentini, A., De, MA and Rotilio, G. (1995) Cell Mol Biol (Noisy-le-grand), 41, p. 1051.
6. Bennett, MR, Gibson, DF, Schwartz, SM and Tait, JF (1995) Circ Res, 77, p. 1136.
7. Hall, SE, Savill, JS, Henson, PM and Haslett, C. (1994) J Immunol, 153, p. 3218.
8. Fadok, VA (1998) J Clin Invest, 101, p. 890.
9. Voll, RE (1997) Nature, 390, p. 350.
10. Ren, Y. (2003) Arthritis Rheum, 48, p. 2888.
11. O'Brien, BA, Fieldus, WE, Field, CJ and Finegood, DT (2002) Cell Death Differ, 9, p. 457.
12. Vandivier, RW (2002) J Clin Invest, 109, p. 661.
13. Hodge, S., Hodge, G., Scicchitano, R., Reynolds, PN and Holmes, M. (2003) Immunol Cell Biol, 81, p. 289.
14. Lauber, K. (2003) Cell, 113, p. 717.
15. Horino, K. (1998) Lab Invest, 78, p. 603.
16. Wakasugi, K. and Schimmel, P. (1999) J Biol Chem, 274, p. 23155.
17. Moodley, Y. (2003) Am J Pathol, 162, p. 771.
18. Fadok, VA (1992) J Immunol, 148, p. 2207.
19. Williamson, P. and Schlegel, RA (2002) Biochim Biophys Acta, 1585, p. 53.
20. Luciani, MF and Chimini, G. (1996) EMBO J, 15, p. 226.
21. Krahling, S., Callahan, MK, Williamson, P. and Schlegel, RA (1999) Cell Death Differ, 6, p. 183.
22. Elliott, JI (2005) Nat Cell Biol, 7, p. 808.
23. Kuijpers, TW (2004) Blood, 103, p. 3915.
24. Dillon, SR, Constantinescu, A. and Schlissel, MS (2001) J Immunol, 166, p. 58.
25. Fadok, VA (2000) Nature, 405, p. 85.
26. Hoffmann, PR (2001) J Cell Biol, 155, p. 649.
27. Bose, J. (2004) J Biol, 3, p. 15.
28. Cui, P., Qin, B., Liu, N., Pan, G. and Pei, D. (2004) Exp Cell Res, 293, p. 154.
29. Cikala, M. (2004) Cell Biol, 5, p. 26.
30. Williamson, P. and Schlegel, RA (2004) J Biol, 3, p. 14.
31. Arur, S. (2003) Dev Cell, 4, p. 587.
32. Lauber, K., Blumenthal, SG, Waibel, M. and Wesselborg, S. (2004) Mol Cell, 14, p. 277.
33. Lauber, K., Blumenthal, SG, Waibel, M. and Wesselborg, S. (2004) Mol Cell, 14, p. 277.
34. Greenberg, ME (2006) J Exp Med, 203, p. 2613.
35. Chang, MK (1999) Proc Natl Acad Sci USA, 96, p. 6353.
36. Platt, N., Suzuki, H., Kurihara, Y., Kodama, T. and Gordon, S. (1996) Proc Natl Acad Sci USA, 93, p. 12456.
37. Oka, K. (1998) Proc Natl Acad Sci USA, 95, p. 9535.
38. Erdosova, B., Hlavkova, L., Prochazkova, J. and Lichnovsky, V. (2002) Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 146, p. 41.
39. Ren, Y., Silverstein, RL, Allen, J. and Savill, J. (1995) J Exp Med, 181, p. 1857.
40. Stern, M., Savill, J. and Haslett, C. (1996) Am J Pathol, 149, p. 911.
41. Takizawa, F., Tsuji, S. and Nagasawa, S. (1996) FEBS Lett, 397, p. 269.
42. Vandivier, RW (2002) J Immunol, 169, p. 3978.
43. Savill, J., Dransfield, I., Hogg, N. and Haslett, C. (1990) Nature, 343, p. 170.
44. Savill, J., Hogg, N., Ren, Y. and Haslett, C. (1992) J Clin Invest, 90, p. 1513.
45. Takizawa, F., Tsuji, S. and Nagasawa, S. (1996) FEBS Lett, 397, p. 269.
46. Vandivier, RW (2002) J Immunol, 169, p. 3978.
47. Gardai, SJ (2005) Cell, 123, p. 321.
48. Gardai, SJ, Bratton, DL, Ogden, CA and Henson, PM (2006) J Leukoc Biol, 79, p. 896.
49. Voll, RE (1997) Nature, 390, p. 350.
50. Fadok, VA (1998) J Clin Invest, 101, p. 890.
51. Gaipl, US (2001) Cell Death Differ, 8, p. 327.
52. Gaipl, US (2004) Arthritis Rheum, 50, p. 640.
53. Hart, SP, Alexander, KM, MacCall, SM and Dransfield, I. (2005) J Inflamm (Lond), 2, p. 5.
54. Devitt, A. (1998) Nature, 392, p. 505.
55. Bottcher, A. (2006) Arthritis Rheum, 54, p. 927.
56. Lauber, K., Blumenthal, SG, Waibel, M. and Wesselborg, S. (2004) Mol Cell, 14, p. 277.
57. Yusa, S., Catina, TL and Campbell, KS (2004) J Immunol, 172, p. 7385.
58. Kharitonenkov, A. (1997) Nature, 386, p. 181.
59. Brown, S. (2002) Nature, 418, p. 200.
60. Oldenborg, PA, Gresham, HD and Lindberg, FP (2001) J Exp Med, 193, p. 855.
61. Oldenborg, PA (2000) Science, 288, p. 2051.
62. Campbell, IG, Freemont, PS, Foulkes, W. and Trowsdale, J. (1992) Cancer Res, 52, p. 5416.
63. Reddien, PW and Horvitz, HR (2000) Nat Cell Biol, 2, p. 131.
64. Gumienny, TL and Hengartner, MO (2001) Cell Death Differ, 8, p. 564.
65. Gardai, SJ, Bratton, DL, Ogden, CA and Henson, PM (2006) J Leukoc Biol, 79, p. 896.
66. Morimoto, K. (2006) J Immunol, 176, p. 7657.
67. Henson PM. Curr Biol 2005;15:R29.
68. Krysko, DV, D'Herde, K. and Vandenabeele, P. (2006) Apoptosis, 11, p. 1709.
69. deBakker, CD (2004) Curr Biol, 14, p. 2208.
70. Zhou, Z., Hartwieg, E. and Horvitz, HR (2001) Cell, 104, p. 43.
71. Liu, Y. (1999) J Immunol, 162, p. 3639.
72. Giles, KM (2001) J Immunol, 167, p. 976.
73. Heasman, SJ (2003) J Endocrinol, 178, p. 29.
74. Yona, S. (2006) J Pharmacol, 148, p. 469.
75. McCutcheon, JC (1998) J Leukoc Biol, 64, p. 600.
76. Kirkham, PA, Spooner, G., Rahman, I. and Rossi, AG (2004) Biochem Biophys Res Commun, 318, p. 32.
77. Henke, CA, Roongta, U., Mickelson, DJ, Knutson, JR and McCarthy, JB (1996) J Clin Invest, 97, p. 2541.
78. Hart, SP, Dougherty, GJ, Haslett, C. and Dransfield, I. (1997) J Immunol, 159, p. 919.
79. Teder, P. (2002) Science, 296, p. 155.
80. Rossi, AG (1998) J Immunol, 160, p. 3562.
81. Oropeza-Rendon, RL, Speth, V., Hiller, G., Weber, K. and Fischer, H. (1979) Exp Cell Res, 119, p. 365.
82. Lang, P. (1996) EMBO J, 15, p. 510.
83. Morimoto, K. (2006) J Immunol, 176, p. 7657.
84. Godson, C. (2000) J Immunol, 164, p. 1663.
85. Gavins, FN, Sawmynaden, P., Chatterjee, BE and Perretti, M. (2005) Prostaglandins Leukot Essent Fatty Acids, 73, p. 211.
86. Hatmi, M., Gavaret, JM, Elalamy, I., Vargaftig, BB and Jacquemin, C. (1996) J Biol Chem, 271, p. 24776.
87. Asch, AS (1993) Science, 262, p. 1436.
88. Godson, C. (2000) J Immunol, 164, p. 1663.
89. Voll, RE (1997) Nature, 390, p. 350.
90. (2006) Blood, 107, p. 4930.
91. Hurst, NP, Nuki, G. and Wallington, T. (1984) Clin Exp Immunol, 55, p. 303.
92. Herrmann, M. (1998) Arthritis Rheum, 41, p. 1241.
93. Baumann, I. (2002) Arthritis Rheum, 46, p. 191.
94. Mahoney, JA and Rosen, A. (2005) Curr Opin Immunol, 17, p. 583.
95. Baumann, I. (2002) Arthritis Rheum, 46, p. 191.
96. Casiano, CA, Martin, SJ, Green, DR and Tan, EM (1996) J Exp Med, 184, p. 765.
97. Price, BE (1996) J Immunol, 157, p. 2201.
98. Hart, SP, Alexander, KM and Dransfield, I. (2004) J Immunol, 172, p. 1882.
99. Savill, J., Dransfield, I., Gregory, C. and Haslett, C. (2002) Nat Rev Immunol, 2, p. 965.
100. Manderson, AP, Botto, M. and Walport, MJ (2004) Annu Rev Immunol, 22, p. 431.
101. Chen, W., Frank, ME, Jin, W. and Wahl, SM (2001) Immunity, 14, p. 715.
102. Sato, K., Yamashita, N. and Matsuyama, T. (2002) Cell Immunol, 215, p. 186.
103. Sauter, B. (2000) J Exp Med, 191, p. 423.
104. Devitt, A. (2004) J Cell Biol, 167, p. 1161.
105. Munoz, LE (2005) Rheumatology (Oxford), 44, p. 1101.
106. Vandivier, RW (2002) J Clin Invest, 109, p. 661.
107. Eisenbarth, GS (1986) N Engl J Med, 314, p. 1360.
108. O'Brien, BA, Fieldus, WE, Field, CJ and Finegood, DT (2002) Cell Death Differ, 9, p. 457.